Pratt Collard Advisory Partners’s Abiomed Inc ABMD Stock Holding History

Pratt Collard Advisory Partners’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,000	Closed	-$554K	–	99
2020 Q3	$554K	Hold	2,000	–	–	0.45%	56
2020 Q2	$483K	Sell	2,000 -200	-9%	-$40.2K	0.43%	60
2020 Q1	$319K	Hold	2,200	–	–	0.32%	67
2019 Q4	$375K	Hold	2,200	–	–	0.29%	74
2019 Q3	$391K	Hold	2,200	–	–	0.31%	69
2019 Q2	$573K	Hold	2,200	–	–	0.45%	59
2019 Q1	$628K	Hold	2,200	–	–	0.5%	57
2018 Q4	$715K	Hold	2,200	–	–	0.65%	47
2018 Q3	$989K	Hold	2,200	–	–	0.79%	42
2018 Q2	$900K	Hold	2,200	–	–	0.78%	42
2018 Q1	$640K	Hold	2,200	–	–	0.56%	58
2017 Q4	$412K	Buy	+2,200	New	+$411K	0.34%	73

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Pratt Collard Advisory Partners's ABMD Position: Q4 2020 in Review

Pratt Collard Advisory Partners sold out of Abiomed Inc (ABMD) in Q4 2020, closing a stake of 2,000 shares — an estimated $554K sold.

Pratt Collard Advisory Partners first reported a position in ABMD in Q4 2017 and held it in 12 quarters. The position peaked at $989K in Q3 2018. 498 funds tracked by Wall St. Rank hold ABMD as of Q4 2020.

Pratt Collard Advisory Partners reported no remaining Abiomed Inc position as of Q4 2020 after selling out during the quarter.
Pratt Collard Advisory Partners sold 2,000 Abiomed Inc shares in Q4 2020, an estimated $554K.
Pratt Collard Advisory Partners first reported a position in Abiomed Inc in Q4 2017 and held it in 12 quarters.
Pratt Collard Advisory Partners's Abiomed Inc position peaked at $989K in Q3 2018.
498 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2020.

Based on Pratt Collard Advisory Partners's 13F filing for Q4 2020, filed 28 Jan 2021.